11. Sources and clinical references

• CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (MMWR Recomm Rep 2022;71(RR-3)) — individualized functional goals, opioid-safety monitoring, naloxone co-prescribing, and constipation management. Verify the current guidance at time of use.
• Sedation-scale and respiratory-rate monitoring guidance for opioid safety (sedation precedes respiratory depression) (verify current source).
• Opioid-induced constipation prevention and management guidance (cross-reference Gastrointestinal).
• CMS Medicare Benefit Policy Manual (Pub. 100-02), Chapter 7 — Home Health Services. Observation and assessment, teaching and training, and management and evaluation of the plan of care.
• 42 CFR Part 484 — Conditions of Participation for Home Health Agencies; comprehensive assessment and care planning.
• CMS OASIS-E2 Guidance Manual, effective April 1, 2026 — relevant pain and clinical items.
• Community Health Accreditation Partner (CHAP) Standards of Excellence for Home Health. [Agency-fill: insert exact title, version, section, and date.]

Standing flags. Display number is provisional; the stable overlay code is the key. The CHAP citation is agency-fill — insert the exact title, version, section, and date. Verify each pinned guideline against the current published edition at time of use.